BD, BioGX Get FDA Emergency Authorization for Three-Hour Coronavirus Test
April 03 2020 - 7:39AM
Dow Jones News
By Dave Sebastian
Becton, Dickinson and Co. and BioGX Inc. said the Food and Drug
Administration has granted an emergency-use authorization for a
coronavirus test that would yield results in under three hours.
The test will run on the BD MAX System, a molecular-diagnostic
platform, the companies said Friday. Each unit can analyze hundreds
of samples a day, they said. The coronavirus pandemic has tested
capacities at medical facilities across the U.S.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
April 03, 2020 07:24 ET (11:24 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
